IDP Discovery Pharma S.L.
1 clinical trials · Sponsor
◉ Watch IDP Discovery Pharma S.L.
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT05908409) | IDP Discovery Pharma S.L. | 2023-06-05 |
Track IDP Discovery Pharma S.L. automatically
Every clearance here is in the API, with alerts when new ones post.